Standards of care and ethical concerns in genetic testing and screening

Clinical Obstetrics and Gynecology

Volumn 39, Issue 4, 1996, Pages 873-884

  Parker, Lisa S ^a   Majeske, Rachel Ankeny ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

AMNIOCENTESIS; BREAST CANCER; CHORION VILLUS SAMPLING; CYSTIC FIBROSIS; EDUCATION; FAMILY HISTORY; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE; HUMAN; INFORMED CONSENT; MASS SCREENING; MASTECTOMY; MATERNAL AGE; MEDICAL ETHICS; PHENOTYPE; PRACTICE GUIDELINE; REVIEW;

GENETICS AND REPRODUCTION;

BREAST NEOPLASMS; CYSTIC FIBROSIS; ETHICS, MEDICAL; FEMALE; GENETIC SCREENING; HUMANS; INFORMED CONSENT; MALE; PRACTICE GUIDELINES; QUALITY OF HEALTH CARE;

EID: 0029803867     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199612000-00014     Document Type: Review

References (41)

1. Andrews LB. Torts and the double helix: Malpractice liability for failure to warn of genetic risks. Houston Law Review. 1992;29:149-184.
2. Chen Y, Chen CF, Riley DJ, et al. Aberrant subcellular localization of BRCA1 in breast cancer. Science. 1995;270:789-91.
3. Draper E. Risky business: genetic testing and exclusionary practices in the hazardous workplace. Cambridge and New York: Cambridge University Press, 1991.
4. Struewing J, Abeliovich D, Peretz T, et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet. 1995;11:198-200.
5. Breo DL. Altered fates - Counseling families with inherited breast cancer. JAMA. 1993;269:2017-2022, 2017.
6. Hoskins KF, Stopfer JE. Assessment and counseling for women with a family history of breast cancer. JAMA. 1995;273:577-585.
7. National Advisory Council for Human Genome Research. Statement on use of DNA testing for presymptomatic identification of cancer risk. JAMA. 1994;271:785.
8. American Society of Human Genetics. Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Hum Genet. 1994;55:i- iv.
9. Collins FS. BRCA1 - Lots of mutations, lots of dilemmas. N Engl J Med. 1996;334:186-188.
10. Elias S, Annas GJ. Generic consent for genetic screening. N Engl J Med. 1994;330:1611-1613.
11. Clarke A. Genetics, ethics, and audit. Lancet. 1990;335:1145-1147.
12. Rosner F. Screening for Tay-Sachs disease: A note of caution. J Clin Ethics. 1991;2:251-252.
13. Clarke A. Is non-directive genetic counselling possible? Lancet. 1991;338:998-1001.
14. Lerman C, Croyle R. Psychological issues in genetic testing for breast cancer susceptibility. Arch Internal Med. 1994;154:609-616.
15. Lerman C, Seay J, Balshem A, et al. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet. 1995;57:385-392.
16. Kuska B. BRCA1 discovery aftermath: No rush for genetic testing. J Natl Cancer Inst. 1995;87:1578-1579.
17. Patenaude AF, Basili L, Fairclough DL, et al. Attitudes of 47 mothers of pediatric oncology patients toward genetic testing for cancer predisposition. J Clin Oncol. 1996;14:415-421.
18. FitzGerald MG, MacDonald DJ, Krainer M, et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med. 1996;334:143-149.
19. Langston AA, Malone KE, Thompson JD, et al BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med. 1996;334:137-142.
20. Grady, D. Findings on breast cancer have only complicated the puzzle: Research into genes raises many hopes and many questions. New York Times 04/30/96, B9.
21. Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. Written by A. Hamosh and M. Corey. N Engl J Med. 1993;329:1308-1313.
22. Hamosh A, Corey M. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med. 1994;329:866-867.
23. Curtis A, Nelson R, Porteous M, et al. Association of less common cystic fibrosis mutations with a mild phenotype. J Med Genet. 1991;28:34-37.
24. Can KH, Heijrman HGM, Bakker W. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med. 1994;330:865-866.
25. Santis G, Osborne L, Knight RA, et al. Linked marker haplotypes and the delta F508 mutation in adults with mild pulmonary disease and cystic fibrosis. Lancet. 1990a;335:1426-1429.
26. al-Jader LN, Meredith AL, Ryley HC, et al. Severity of chest disease in cystic fibrosis patients in relation to their genotypes. J Med Genet. 1992;29:883-887.
27. Santis G, Osborne L, Knight RA, et al. Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet. 1990b;336:1081-1084.
28. Liechti-Gallati S, Bonsall I, Malik N, et al. Genotype/phenotype association in cystic fibrosis: analyses of the delta F508, R553X, and 3905insT mutations. Pediatr Res. 1992;32:175-178.
29. Charo RA. Legal and regulatory issues surrounding carrier testing. Clin Obstet Gynecol. 1993;36:568-597.
30. Wilfond BS,Fost N. The introduction of cystic fibrosis carrier screening into clinical practice: Policy considerations. The Milbank Quarterly. 1992;70:629-659.
31. Biesecker BB, Boehnke M, Calzone, K, et al. 1993. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA. 1993;269:1970-1974.
32. Quaid K. Presymptomatic testing for adult-onset genetic disease: recommendations for counseling. J Genet Counsel. 1992;1:277-302.
33. Alagna SW, Morokoff PJ, Bevett JM, et al. Performance of breast self-examination by women at high risk for breast cancer. Women & Health. 1987;12:29-46.
34. Lerman C, Daly M, Sands C, et al. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst. 1993;85:1074-1080.
35. Billings PR, Kohn MA, de Cuevas M, et al. Discrimination as a consequence of genetic testing. Am J Hum Genet. 1992;50:476-482.
36. McEwen JE, McArty K, Reilly PR. A survey of state insurance commissioners concerning genetic testing and life insurance. Am J Hum Genet. 1992;51:785-792.
37. Natowicz MR, Alper J, Alper JS. Genetic discrimination and the law. Am J Hum Genet. 1992;50:465-475.
38. Anonymous. Genetic testing and insurance. The Ad Hoc Committee on Genetic Testing/Insurance Issues. Am J Hum Genet. 1995;56:327-331.
39. Council on Ethical and Judicial Affairs of the American Medical Association. Use of genetic testing by employers. JAMA. 1991;266:1827-1830.
40. The Research Institute of America, Inc. Analysis of the Americans with Disabilities Act and the EEOC Regulations. 1991.
41. Parmet WE. Discrimination and disability: the challenges to the ADA. Law, Medicine, & Health Care. 1990;18:331-344.